Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

PHASE3CompletedINTERVENTIONAL
Enrollment

698

Participants

Timeline

Start Date

September 7, 2012

Primary Completion Date

January 5, 2018

Study Completion Date

January 5, 2018

Conditions
Meningococcal Infection
Interventions
PROCEDURE

blood sampling

Blood sample collection at different time points

DRUG

bivalent rLP2086

A booster dose of bivalent rLP2086 at approximately 48 months following the final dose of the 2- or 3-dose primary bivalent rLP2086 vaccination series will be given at Visit 7.

Trial Locations (56)

8200

Aarhus University hospital Skejby, Aarhus N

14000

Ordinace praktickeho lekare pro deti a dorost, Praha - Nusle

16000

Ordinace praktickeho lekare pro deti a dorost, Prague

20520

Turku Vaccine Research Clinic, Turku

25070

Ordinace praktickeho lekare pro deti a dorost, Odolena Voda

28100

Pori Vaccine Research Clinic, Pori

30062

Pediatrics and Adolescent Medicine, PA, Marietta

30189

Pediatrics And Adolescent Medicine, P.A., Woodstock

30721

North Georgia Research Clinical Center, Dalton

33100

Tampere Vaccine Research Clinic, Tampere

33606

USF Health South Tampa Center for Advanced Healthcare, Tampa

USF Health, Tampa

37701

Ordinace praktickeho lekare pro deti a dorost, Jindřichův Hradec

40004

Kentucky Pediatric/Adult Research, Bardstown

40202

U of L Pediatrics: Downtown, Louisville

40207

Brownsboro Park Pediatrics, Louisville

40291

Bluegrass Clinical Research, Inc., Louisville

44121

Dr. Shelly David Senders MD Inc. dba Senders Pediatrics, Cleveland

45414

Ohio Pediatric Research Association, Dayton

Ohio Pediatrics, Inc, Dayton

49127

Southwestern Medical Clinic Lakeland Healthcare Affiliate, Stevensville

49565

Kinderarzt Praxis, Bramsche

50002

Ordinace praktickeho lekare pro deti a dorost, Hradec Králové

50004

Ordinace praktickeho lekare pro deti a dorost, Hradec Králové

50005

Fakultni nemocnice Hradec Kralove, Hradec Králové

51503

Clinical Research Advantage, Inc., Council Bluffs

53002

Ordinace praktickeho lekare pro deti a dorost, Pardubice

53012

Ordinace praktickeho lekare pro deti a dorost, Pardubice

53304

Ordinace praktickeho lekare pro deti a dorost, Sezemice

53401

Ordinace praktickeho lekare pro deti a dorost, Holice

53566

Monroe Clinic, Monroe

Research and Education Association for Clinical Health, Inc., Monroe

64114

The Center For Pharmaceutical Research, Kansas City

67010

Heartland Research Associates, LLC, Augusta

68025

Clinical Research Advantage, Inc. (Prairie Fields Family Medicine, PC), Fremont

68131

Creighton University Pediatric Infectious Diseases, Omaha

68504

Midwest Children's Health Research Institute, Lincoln

77055

West Houston Clinical Research Service (WHCRS), Houston

83642

Advanced Clinical Research, Meridian

84095

J. Lewis Research Inc, Jordan River Family Medicine, South Jordan

84109

J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City

84121

J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City

84124

BB Holdings, LLC., dba Jean Brown Research, Salt Lake City

85224

Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC, Chandler

Clinical Research Advantage, Inc./ East Valley Family Physicians, PLC, Chandler

88348

Kinder - und Jugendarzt Praxis, Bad Saulgau

89014

Clinical Research Center of Nevada,LLC, Henderson

90723

Center For Clinical Trials, LLC, Paramount

91607

Bayview Research Group, Valley Village

92123

California Research Foundation, San Diego

92648

St. Joseph Heritage Healthcare, Huntington Beach

98664

The Vancouver Clinic, Inc. PS, Vancouver

84088-9334

Advanced Clinical Research, West Jordan

04400

Jarvenpaa Vaccine Research Clinic, Järvenpää

631 88

Infektionskliniken Malarsjukhuset, Eskilstuna

205 02

Skanes Universitetssjukhus, Malmo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01543087 - Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose | Biotech Hunter | Biotech Hunter